Home › Funds › FORBES J M & CO LLP › ABT

FORBES J M & CO LLP position in ABT

ABBOTT LABORATORIES · Health Care

FORBES J M & CO LLP reported holding 141,334 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$14.0M, representing 1.22% of its reported portfolio and ranking #27 among its reported holdings. FORBES J M & CO LLP has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)141.33K sh
Reported value held$13.97M
Portfolio Weight1.22%
First reportedQ3 2023
Last changeAdd
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How FORBES J M & CO LLP's ABT position evolved

FORBES J M & CO LLP first disclosed a stake in ABT in Q3 2023 at 134,358 shares (US$13.0M). The position peaked in Q2 2025 at 138,076 shares, worth US$18.8M. Across 13 filings, FORBES J M & CO LLP increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 141,334 shares valued at US$14.0M — an increase of 806 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 134.36K $13.01M New
Q4 2023 135.58K $14.92M Add
Q1 2024 134.18K $15.25M Reduce
Q2 2024 135.92K $14.12M Add
Q3 2024 135.19K $15.41M Reduce
Q4 2024 135.60K $15.34M Hold
Q1 2025 139.88K $18.56M Add
Q2 2025 138.08K $18.78M Reduce
Q3 2025 139.00K $18.62M Add
Q4 2025 139.53K $17.48M Hold
Q1 2026 141.21K $14.50M Add
Q2 2026 140.53K $12.75M Hold
Q3 2026 141.33K $13.97M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has FORBES J M & CO LLP held ABT?

FORBES J M & CO LLP has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FORBES J M & CO LLP's current position in ABT?

As of Q3 2026, FORBES J M & CO LLP holds 141.33K shares of ABT (ABBOTT LABORATORIES), valued at $13.97M, representing 1.22% of its reported portfolio and ranking #27.

Has FORBES J M & CO LLP been buying or selling ABT?

In the latest 13F filing (Q3 2026), FORBES J M & CO LLP increased its position in ABT. The position peaked in Q2 2025 at 138.08K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.